Duke University Medical Center; University of North Carolina at Chapel Hill
- Advisory Board: Medscape from WebMD
- Consultant: Abbott Laboratories; AstraZeneca LP; Biovail Corporation; Bristol-Myers Squibb; Cephalon, Inc; Corcept Therapeutics Incorporated; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Medscape from WebMD; Organon International Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Pharmacia; Sanofi-Synthélabo; Shire Pharmaceuticals Inc.; Solvay Pharmaceuticals; Sunovion Pharmaceuticals Inc.; TransTech Pharma, Inc.; Transcept Pharmaceuticals, Inc.; Validus Pharmaceuticals LLC; Wyeth; sanofi-aventis
- Research Support: Abbott Laboratories; AstraZeneca LP; Biovail Corporation; Bristol-Myers Squibb; Burroughs Wellcome Fund; CeNeRx BioPharma; Cephalon, Inc; Ciba-Geigy Chemical Corporation; CoMentis, Inc.; Dainippon Sumitomo Pharma Co., Ltd.; Eisai Inc.; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc.; Johnson & Johnson; Lundbeck; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; MediciNova, Inc.; Merck & Co., Inc.; National Institute of Mental Health; Neurochem Inc.; New River Pharmaceuticals Inc.; Novartis Pharmaceutical Corporation; Organon International Inc.; Pfizer Inc; Pharmacia; Repligen Corporation; Saegis Pharmaceuticals, Inc.; Sandoz Ltd. ; Sanofi-Synthélabo; Schwabe/Ingenix; Sepracor Inc.; Shire Pharmaceuticals Inc.; Sunovion Pharmaceuticals Inc.; Synaptic Pharmaceutical Corporation; TAP Pharmaceuticals ; Takeda Pharmaceutical Company Limited; TransTech Pharma, Inc.; Transcept Pharmaceuticals, Inc.; UCB S.A.; Vela Pharmaceuticals Inc.; Wyeth; sanofi-aventis
- Speakers Bureau: Abbott Laboratories; AstraZeneca LP; Biovail Corporation; Bristol-Myers Squibb; Burroughs Wellcome Fund; Cephalon, Inc; Ciba-Geigy Chemical Corporation; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc.; Johnson & Johnson; Novartis Pharmaceutical Corporation; Organon International Inc.; Pfizer Inc; Sanofi-Synthélabo; Shire Pharmaceuticals Inc.; Solvay Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Validus Pharmaceuticals LLC; Wyeth; sanofi-aventis
- Stock or Equity: Bristol-Myers Squibb; Cortex Pharmaceuticals; Merck & Co., Inc.; Pfizer Inc